Astellas Pharma Korea, Inc.
Clinical trials sponsored by Astellas Pharma Korea, Inc., explained in plain language.
-
New study tracks safety of VYLOY in everyday cancer care
Disease control Recruiting nowThis study monitors 377 South Korean patients with advanced stomach or gastroesophageal junction cancer who receive VYLOY (zolbetuximab) as part of their normal treatment. Researchers will track side effects and how long the cancer stays stable. The goal is to confirm the drug's …
Sponsor: Astellas Pharma Korea, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
South korea tracks Real-World safety of bladder cancer drug PADCEV
Knowledge-focused Recruiting nowThis study monitors 202 adults in South Korea with advanced bladder cancer who are receiving the drug PADCEV (enfortumab vedotin) as part of their normal care. Researchers will track side effects and how well the cancer responds for up to a year. No new treatment is given; the go…
Sponsor: Astellas Pharma Korea, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC